405231-13-2

Basic information

• Product Name: 4,6,7-trifluoro-3-(2,3,5-tri-O-benzoyl-β-D-ribofuranosyl)imidazo[4,5-c]pyridine
• CAS NO: 405231-13-2
• Molecular Weight: 617.538
• Mol File: 405231-13-2.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: 4,6,7-trifluoro-3-(2,3,5-tri-O-benzoyl-β-D-ribofuranosyl)imidazo[4,5-c]pyridine(CAS DataBase Reference)
• NIST Chemistry Reference: 4,6,7-trifluoro-3-(2,3,5-tri-O-benzoyl-β-D-ribofuranosyl)imidazo[4,5-c]pyridine(405231-13-2)
• EPA Substance Registry System: 4,6,7-trifluoro-3-(2,3,5-tri-O-benzoyl-β-D-ribofuranosyl)imidazo[4,5-c]pyridine(405231-13-2)

Safety Data

• Hazardous Substances Data: 405231-13-2(Hazardous Substances Data)

Upstream product

• 6974-32-9 1-O-acetyl-2,3,5-tri-O-benzoyl-β-D-ribofuranose 
• 405230-95-7 4,6,7-trifluoroimidazo[4,5-c]pyridine 
• 405231-20-1 1-[(1-acetyloxy-1-ethoxy)methyl]-4,6,7-trifluoroimidazo[4,5-c]pyridine 
• 405230-88-8 4-amino-3-nitro-2,5,6-trifluoropyridine 
• 405230-83-3 4-nitramino-2,3,6-trifluoropyridine 
• 1735-84-8 3-chloro-2,4,5,6-tetrafluoropyridine 
• 2693-57-4 4-amino-3-chloro-2,5,6-trifluoropyridine 
• 6256-96-8 3,4-diamino-2,5,6-trifluoropyridine 
• 63489-55-4 4-Amino-2,3,6-trifluoropyridine 

Relevant articles and documents

Novel nucleosides and related processes, pharmaceutical compositions and methods

The invention provides novel nucleosides and related processes, pharmaceutical compositions, and methods. The novel nucleosides are useful in a wide variety of antiviral, antineoplastic, and antibacterial applications. Preferred embodiments of the instant invention include novel 2 halogen-substituted, 3 halogen-substituted, and 2′,3′dihalogen-substituted analogues of 3-deazaadenosine, and novel 3 halogen-substituted analogues of 3-deazaguanosine. Compounds of the instant invention, including 4-Amino-6-fluoro-1-(β-D-ribofuranosyl)imidazo[4,5-c]pyridine and 6-Amino-7-bromo-1,5-dihydro-1-β-D-ribofuranosylimidazo[4,5-c]pyridin-4-one, have exhibited potent antiviral and anticancer activity in vitro. The compounds are also useful in the concomitant treatment of bacterial infections associated with viral infections such as AIDS.